Mark Massaro
Stock Analyst at BTIG
(4.52)
# 271
Out of 5,117 analysts
176
Total ratings
54.78%
Success rate
20.77%
Average return
Main Sectors:
Stocks Rated by Mark Massaro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDXH MDxHealth | Reiterates: Buy | $7 | $3.41 | +105.28% | 10 | Dec 23, 2025 | |
| GH Guardant Health | Maintains: Buy | $100 → $140 | $102.98 | +35.95% | 7 | Dec 12, 2025 | |
| WGS GeneDx Holdings | Maintains: Buy | $165 → $200 | $133.79 | +49.49% | 7 | Dec 12, 2025 | |
| CSTL Castle Biosciences | Maintains: Buy | $38 → $50 | $39.40 | +26.92% | 6 | Dec 12, 2025 | |
| BLLN BillionToOne | Reiterates: Buy | $160 | $89.30 | +79.17% | 2 | Dec 10, 2025 | |
| NTRA Natera | Maintains: Buy | $230 → $260 | $233.74 | +11.23% | 16 | Dec 5, 2025 | |
| ZTS Zoetis | Reiterates: Buy | $160 | $126.23 | +26.75% | 4 | Dec 3, 2025 | |
| TEM Tempus AI | Maintains: Buy | $96 → $105 | $62.70 | +67.46% | 6 | Nov 25, 2025 | |
| EXAS Exact Sciences | Downgrades: Neutral | n/a | $101.57 | - | 20 | Nov 20, 2025 | |
| PSNL Personalis | Maintains: Buy | $11 → $12 | $8.14 | +47.42% | 3 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $15 | $6.13 | +144.70% | 5 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $7 | $4.73 | +47.99% | 3 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $19.48 | +28.34% | 5 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $21 | $16.70 | +25.75% | 7 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $785 → $830 | $688.48 | +20.56% | 2 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2.5 | $1.09 | +129.36% | 4 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $6 → $9 | $8.40 | +7.14% | 7 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.61 | - | 4 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.52 | - | 8 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $21 | $12.28 | +71.01% | 4 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.04 | - | 1 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.03 | - | 1 | Jan 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $350 → $300 | $134.95 | +122.30% | 6 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $52 → $50 | $74.50 | -32.89% | 9 | Nov 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $112 | $175.94 | -36.34% | 10 | Jul 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $155 → $165 | $253.89 | -35.01% | 10 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $80 | $29.30 | +173.04% | 9 | Sep 10, 2018 |
MDxHealth
Dec 23, 2025
Reiterates: Buy
Price Target: $7
Current: $3.41
Upside: +105.28%
Guardant Health
Dec 12, 2025
Maintains: Buy
Price Target: $100 → $140
Current: $102.98
Upside: +35.95%
GeneDx Holdings
Dec 12, 2025
Maintains: Buy
Price Target: $165 → $200
Current: $133.79
Upside: +49.49%
Castle Biosciences
Dec 12, 2025
Maintains: Buy
Price Target: $38 → $50
Current: $39.40
Upside: +26.92%
BillionToOne
Dec 10, 2025
Reiterates: Buy
Price Target: $160
Current: $89.30
Upside: +79.17%
Natera
Dec 5, 2025
Maintains: Buy
Price Target: $230 → $260
Current: $233.74
Upside: +11.23%
Zoetis
Dec 3, 2025
Reiterates: Buy
Price Target: $160
Current: $126.23
Upside: +26.75%
Tempus AI
Nov 25, 2025
Maintains: Buy
Price Target: $96 → $105
Current: $62.70
Upside: +67.46%
Exact Sciences
Nov 20, 2025
Downgrades: Neutral
Price Target: n/a
Current: $101.57
Upside: -
Personalis
Nov 11, 2025
Maintains: Buy
Price Target: $11 → $12
Current: $8.14
Upside: +47.42%
Nov 10, 2025
Maintains: Buy
Price Target: $13 → $15
Current: $6.13
Upside: +144.70%
Nov 10, 2025
Maintains: Buy
Price Target: $6 → $7
Current: $4.73
Upside: +47.99%
Nov 6, 2025
Maintains: Buy
Price Target: $22 → $25
Current: $19.48
Upside: +28.34%
Nov 6, 2025
Maintains: Buy
Price Target: $19 → $21
Current: $16.70
Upside: +25.75%
Nov 4, 2025
Maintains: Buy
Price Target: $785 → $830
Current: $688.48
Upside: +20.56%
Sep 10, 2025
Reiterates: Buy
Price Target: $2.5
Current: $1.09
Upside: +129.36%
Aug 25, 2025
Maintains: Sell
Price Target: $6 → $9
Current: $8.40
Upside: +7.14%
Aug 11, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.61
Upside: -
Sep 10, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.52
Upside: -
May 2, 2024
Maintains: Buy
Price Target: $23 → $21
Current: $12.28
Upside: +71.01%
Mar 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $4.04
Upside: -
Jan 20, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.03
Upside: -
Sep 22, 2020
Maintains: Hold
Price Target: $350 → $300
Current: $134.95
Upside: +122.30%
Nov 11, 2019
Maintains: Hold
Price Target: $52 → $50
Current: $74.50
Upside: -32.89%
Jul 24, 2019
Maintains: Buy
Price Target: $108 → $112
Current: $175.94
Upside: -36.34%
May 2, 2019
Maintains: Hold
Price Target: $155 → $165
Current: $253.89
Upside: -35.01%
Sep 10, 2018
Maintains: Buy
Price Target: $78 → $80
Current: $29.30
Upside: +173.04%